Literature DB >> 2720514

Case-control study of hydrocarbon exposures in patients with renal cell carcinoma.

C R Sharpe1, J E Rochon, J M Adam, S Suissa.   

Abstract

A retrospective case-control study tested the hypothesis that exposure to hydrocarbon combustion products is associated with the development of renal cell carcinoma. One control per case, matched for sex, date of birth (within 5 years) and urologist, was chosen. Controls were patients who presented with hematuria and were shown not to have a urinary tract tumour. A total of 164 cases and 161 controls responded to mailed questionnaires and telephone interviews. Smoking more than 20 cigarettes per day was associated with the presence of metastatic renal cell carcinoma (p less than 0.001). Exposure to burning coal was associated with an increased relative risk of the disease but only when the exposure occurred between the ages of 10 and 24 years (p less than 0.05). Dose-response relations were demonstrated for intensity of exposure (p less than 0.025) and duration of occupational exposure (p less than 0.05). The distribution of latent periods from first exposure to diagnosis was bimodal, with one mode at 21 to 30 years and another at 41 to 50 years. Occupational exposure to tar or pitch or both was also associated with an increased relative risk of renal cell carcinoma (p less than 0.05).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2720514      PMCID: PMC1269190     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  35 in total

1.  Study of five hundred patients with asymptomatic microhematuria.

Authors:  L F GREENE; E J O'SHAUGHNESSY; E D HENDRICKS
Journal:  J Am Med Assoc       Date:  1956-06-16

Review 2.  Current models of steroid hormone action: a critique.

Authors:  J Gorski; F Gannon
Journal:  Annu Rev Physiol       Date:  1976       Impact factor: 19.318

3.  A 5-year follow-up of undiagnosed haematuria.

Authors:  G V Appleton; G D Lutchman; C A Charlton
Journal:  Br J Urol       Date:  1986-10

4.  Accuracy of ultrasound in predicting the nature of renal masses.

Authors:  D A Lingard; T L Lawson
Journal:  J Urol       Date:  1979-12       Impact factor: 7.450

Review 5.  The 1986 Bernard B. Brodie award lecture. The genetic regulation of drug-metabolizing enzymes.

Authors:  D W Nebert
Journal:  Drug Metab Dispos       Date:  1988 Jan-Feb       Impact factor: 3.922

6.  The prosence of estrogen receptor in kidneys from normal and androgen-insensitive tfm/y mice.

Authors:  L P Bullock; C W Bardin
Journal:  Endocrinology       Date:  1975-11       Impact factor: 4.736

7.  Activation of c-Ha-ras-1 proto-oncogene by in vitro modification with a chemical carcinogen, benzo(a)pyrene diol-epoxide.

Authors:  C J Marshall; K H Vousden; D H Phillips
Journal:  Nature       Date:  1984 Aug 16-22       Impact factor: 49.962

8.  A population--based case--control study of renal cell carcinoma.

Authors:  J K McLaughlin; J S Mandel; W J Blot; L M Schuman; E S Mehl; J F Fraumeni
Journal:  J Natl Cancer Inst       Date:  1984-02       Impact factor: 13.506

9.  Chronic renal failure: a significant risk factor in the development of acquired renal cysts and renal cell carcinoma. Case reports and review of the literature.

Authors:  P N Bretan; M P Busch; H Hricak; R D Williams
Journal:  Cancer       Date:  1986-05-01       Impact factor: 6.860

10.  A cohort mortality study of petrochemical workers.

Authors:  S G Austin; A R Schnatter
Journal:  J Occup Med       Date:  1983-04
View more
  9 in total

1.  Occupational exposure to perchloroethylene.

Authors:  K Ulm; D Henschler; S Vamvakas
Journal:  Cancer Causes Control       Date:  1996-03       Impact factor: 2.506

2.  Occupational trichloroethylene exposure and renal carcinoma risk: evidence of genetic susceptibility by reductive metabolism gene variants.

Authors:  Lee E Moore; Paolo Boffetta; Sara Karami; Paul Brennan; Patricia S Stewart; Rayjean Hung; David Zaridze; Vsevolod Matveev; Vladimir Janout; Helena Kollarova; Vladimir Bencko; Marie Navratilova; Neonila Szeszenia-Dabrowska; Dana Mates; Jan Gromiec; Ivana Holcatova; Maria Merino; Stephen Chanock; Wong-Ho Chow; Nathaniel Rothman
Journal:  Cancer Res       Date:  2010-07-27       Impact factor: 12.701

3.  Mortality study of employees engaged in the manufacture and use of hydroquinone.

Authors:  J W Pifer; F T Hearne; F A Swanson; J L O'Donoghue
Journal:  Int Arch Occup Environ Health       Date:  1995       Impact factor: 3.015

4.  Risk factors for kidney cancer in New South Wales. IV. Occupation.

Authors:  M McCredie; J H Stewart
Journal:  Br J Ind Med       Date:  1993-04

Review 5.  Critical review of the epidemiological literature on occupational exposure to perchloroethylene and cancer.

Authors:  Kenneth A Mundt; Thomas Birk; Margaret T Burch
Journal:  Int Arch Occup Environ Health       Date:  2003-07-29       Impact factor: 3.015

Review 6.  Cancer in relation to occupational exposure to perchloroethylene.

Authors:  N S Weiss
Journal:  Cancer Causes Control       Date:  1995-05       Impact factor: 2.506

7.  Epidemiologic characteristics and risk factors for renal cell cancer.

Authors:  Loren Lipworth; Robert E Tarone; Lars Lund; Joseph K McLaughlin
Journal:  Clin Epidemiol       Date:  2009-08-09       Impact factor: 4.790

Review 8.  Trichloroethylene and cancer: epidemiologic evidence.

Authors:  D Wartenberg; D Reyner; C S Scott
Journal:  Environ Health Perspect       Date:  2000-05       Impact factor: 9.031

9.  Elevated urinary mutagenicity among those exposed to bituminous coal combustion emissions or diesel engine exhaust.

Authors:  Jason Y Y Wong; Roel Vermeulen; Yufei Dai; Wei Hu; W Kyle Martin; Sarah H Warren; Hannah K Liberatore; Dianzhi Ren; Huawei Duan; Yong Niu; Jun Xu; Wei Fu; Kees Meliefste; Jufang Yang; Meng Ye; Xiaowei Jia; Tao Meng; Bryan A Bassig; H Dean Hosgood; Jiyeon Choi; Mohammad L Rahman; Douglas I Walker; Yuxin Zheng; Judy Mumford; Debra T Silverman; Nathaniel Rothman; David M DeMarini; Qing Lan
Journal:  Environ Mol Mutagen       Date:  2021-08-16       Impact factor: 3.579

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.